A RANDOMIZED, CONTROLLED, DOUBLE-MASKED, CROSSOVER CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EXPLORATORY EFFICACY OF 1.0 mg LUMINATE® (ALG-1001) AS A TREATMENT FOR NON-EXUDATIVE MACULAR DEGENERATION
Research Grant
Administered By
Ophthalmology
Awarded By
Allegro Ophthalmics, LLC
Start Date
May 8, 2017
End Date
December 31, 2019
Administered By
Ophthalmology
Awarded By
Allegro Ophthalmics, LLC
Start Date
May 8, 2017
End Date
December 31, 2019